LifeStance Health Group, Inc.
NASDAQ:LFST
6.74 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 1,055.665 | 859.542 | 667.511 | 377.217 | 212.518 |
| Cost of Revenue
| 834.006 | 622.525 | 466.003 | 242.897 | 150.122 |
| Gross Profit
| 221.659 | 237.017 | 201.508 | 134.32 | 62.396 |
| Gross Profit Ratio
| 0.21 | 0.276 | 0.302 | 0.356 | 0.294 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 410.793 | 377.993 | 433.725 | 69.646 | 41.06 |
| Selling & Marketing Expenses
| -1.786 | 8.632 | 1.942 | 2.605 | 0.646 |
| SG&A
| 409.007 | 377.993 | 433.725 | 330.736 | 41.06 |
| Other Expenses
| -0.112 | 69.198 | 54.136 | 0 | 6.095 |
| Operating Expenses
| 409.007 | 447.191 | 487.861 | 330.736 | 47.155 |
| Operating Income
| -187.348 | -210.174 | -286.353 | 15.436 | 15.241 |
| Operating Income Ratio
| -0.177 | -0.245 | -0.429 | 0.041 | 0.072 |
| Total Other Income Expenses Net
| -19.235 | -22.556 | -46.752 | -59.847 | -7.366 |
| Income Before Tax
| -206.583 | -232.73 | -333.105 | -44.411 | 7.875 |
| Income Before Tax Ratio
| -0.196 | -0.271 | -0.499 | -0.118 | 0.037 |
| Income Tax Expense
| -20.321 | -17.166 | -25.908 | -6.341 | 2.206 |
| Net Income
| -186.262 | -215.564 | -307.197 | -38.07 | 5.669 |
| Net Income Ratio
| -0.176 | -0.251 | -0.46 | -0.101 | 0.027 |
| EPS
| -0.51 | -0.61 | -0.94 | -0.1 | 0.015 |
| EPS Diluted
| -0.51 | -0.61 | -0.94 | -0.1 | 0.015 |
| EBITDA
| -106.911 | -141.194 | -233.686 | 46.481 | 21.336 |
| EBITDA Ratio
| -0.101 | -0.164 | -0.35 | 0.123 | 0.1 |